1. Arababadi MK, Pourfathollah AA, Jafarzadeh A, Hassanshahi G. Decreased expression of CCR5 on the NK cells in occult HBV infected patients. LabMed 2010; 41:735-738.
2. Arababadi MK, Nasiri Ahmadabadi B, Kennedy D. Current information on the immunologic status of occult hepatitis B infection. Transfusion 2012; 52:1819-1826.
3. Seeram NP, Zhang Y, Henning SM, Lee R, Niu Y, Lin G, et al. Pistachio skin phenolics are destroyed by bleaching resulting in reduced antioxidative capacities. J Agric Food Chem 2006; 54:7036-7040.
4. Karimabad MN, Arababadi MK, Hakimizadeh E, Daredori HY, Nazari M, Hassanshahi G, et al. Is the IL-10 promoter polymorphism at position -592 associated with immune system-related diseases? Inflammation 2013; 36:35-41.
5. Arababadi MK, Mosavi R, Khorramdelazad H, Yaghini N, Zarandi ER, Araste M, et al. Cytokine patterns after therapy with Avonex(R), Rebif(R), Betaferon(R) and CinnoVex in relapsing-remitting multiple sclerosis in Iranian patients. Biomark Med 2010; 4:755-759.
6. Arababadi MK, Pourfathollah AA, Jafarzadeh AA, Hassanshahi G. Serum levels of Interleukin (IL)-10 and IL-17A in occult HBV infected south-east Iranian patients. Hepat Mon 2010; 10:31-35.
7. del Rio L, Barbera-Cremades M, Navarro JA, Buendia AJ, Cuello F, Ortega N, et al. IFN-gamma expression in placenta is associated to resistance to Chlamydia abortus after intragastric infection. Microb Pathog 2013; 56:1-7.
8. Chang HH, Reich BJ, Miranda ML. Time-to-event analysis of fine particle air pollution and preterm birth: results from North Carolina, 2001–2005. Americ J Epidem 2012;175(2):91-8
9. Mitchell‐Lewis D, Engebretson SP, Chen J, Lamster IB, Papapanou PN. Periodontal infections and pre‐term birth: early findings from a cohort of young minority women in New York. Eur J Oral Sci 2001; 109:34-39.
10. Hemminki E, Starfield B. Prevention of low birth weight and pre-term birth: literature review and suggestions for research policy. Milbank Mem Fund Q Health Soc 1977; 56:339-361.
11. Groux H, Cottrez F. The complex role of interleukin-10 in autoimmunity. J Autoimmun 2003; 20:281-285.
12. Scapini P, Lamagna C, Hu Y, Lee K, Tang Q, Defranco AL, et al. B cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient mice. Proc Natl Acad Sci U S A 2011; 108;E823-832.
13. Sabat R, Grutz G, Warszawska K, Kirsch S, Witte E, Wolk K, et al. Biology of interleukin-10. Cytokine Growth Factor Rev 2010; 21:331-344.
14. Howell WM, Rose-Zerilli MJ. Interleukin-10 polymorphisms, cancer susceptibility and prognosis. Fam Cancer 2006; 5:143-149.
15. Shah N, Kammermeier J, Elawad M, Glocker E-O. Interleukin-10 and interleukin-10–receptor defects in inflammatory bowel disease. Curr Allergy Asthma Rep 2012; 12:373-379.
16. Kontoyiannis D, Kotlyarov A, Carballo E, Alexopoulou L, Blackshear PJ, Gaestel M, et al. Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology. EMBO J 2001; 20:3760-3770.
17. Donnelly RP, Dickensheets H, Finbloom DS. The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J Interferon Cytokine Res 1999; 19:563-573.
18. Gaba A, Grivennikov SI, Do MV, Stumpo DJ, Blackshear PJ, Karin M. Cutting edge: IL-10–mediated tristetraprolin induction is part of a feedback loop that controls macrophage STAT3 activation and cytokine production. J Immunol 2012; 189:2089-2093.
19. Takagi H, Sanada T, Minoda Y, Yoshimura A. Regulation of cytokine and toll-like receptor signaling by SOCS family genes. Nihon Rinsho Japan J Clin Med 2004; 62:2189.
20. Strle K, Zhou J-H, Broussard SR, Venters HD, Johnson RW, Freund GG, et al. IL-10 promotes survival of microglia without activating Akt. J Neuroimmunol 2002; 122:9-19.
21. Bebien M, Hensler ME, Davanture S, Hsu L-C, Karin M, Park JM, et al. The pore-forming toxin β hemolysin/cytolysin triggers p38 MAPK-dependent IL-10 production in macrophages and inhibits innate immunity. PLoS Pathog 2012; 8:e1002812.
22. Hakimi H, Zare-Bidaki M, Zainodini N, Assar S, Arababadi MK. Significant roles played by IL-10 in chlamydia infections. Inflammation 2014; 37: 818-823.
23. Lin H, Mosmann MT, Guilbert L, Tuntipopipat S, Wegmann TG.Synthesis of T helper 2-type cytokines at the maternal-fetal interface. Synthesis, maternal-fetal oTh-tcat, interface. J Immunol 1993; 151:4562-4573.
24. Bennett WA, Lagoo-Deenadayalan S, Whitworth NS, Stopple JA, Barber, WH, Hale E, et al. First-trimester human, inflammatory cvebia, the carfi-ir, cytokine network of pregnancy. Am J Reprod Immunol 1999: 41:70-78.
25. Bennett W, Lagoo-Deenadayalan S, Whitworth N, Brackin M, Hale E, Cowan B. Expression and production of interleukin-10 by human trophoblast: relationship to pregnancy immunotolerance. Biol Med: Official J Societ Invest Early Pregn 1997; 3:190-198.
26. Robertson SA, Skinner RJ, Care AS. Essential role for IL-10 in resistance to lipopolysaccharide-induced preterm labor in mice. J Immunol 2006; 177:4888-4896.
27. Aisemberg J, Vercelli CA, Bariani MV, Billi SC, Wolfson ML, Franchi AM. Progesterone is essential for protecting against LPS-induced pregnancy loss. LIF as a potential mediator of the anti-inflammatory effect of progesterone. PloS One 2013; 8:e56161.
28. Rivera DL, Olister SM, Liu X, Thompson JH, Zhang XJ, Pennline K, et al. Interleukin-10 attenuates experimental fetal growth restriction and demise. FASEB J 1998; 12:189–197.
29. Terrone DA, Rinehart BK, Granger JP, Barrilleaux PS, Martin JN Jr, Bennett WA. Interleukin-10 administration and bacterial endotoxininduced preterm birth in a rat model. Obstet Gynecol 2001; 98:476–480.
30.Gotsch F, Romero R, Kusanovic JP, Erez O, Espinoza J, Kim CJ, et al. The anti-inflammatory limb of the immune response in preterm labor, intra-amniotic infection/inflammation, and spontaneous parturition at term: a role for interleukin-10. J Matern Fetal Neonatal Med 2008; 21:529-547.
31. Elovitz MA, Mrinalini C. The use of progestational agents for preterm birth: lessons from a mouse model. Am J Obstet Gynecol 2006; 195:1004-1010.
32. Puchner K, Iavazzo C, Gourgiotis D, Boutsikou M, Baka S, Hassiakos D, et al. Mid-trimester amniotic fluid interleukins (IL-1β, IL-10 and IL-18) as possible predictors of preterm delivery. In Vivo 2011; 25:141-148.
33. Arababadi MK, Aminzadeh F, Hassanshahi G, Khoramdelazad H, Karimabad MN, zarandi ER, et al. Cytokines in Preterm Delivery. Lab Med 2012; 43:131-134.
34. Tatad AF, Nesin M, Peoples J, Cheung S, Lin H, Sison C, et al. Cytokine expression in response to bacterial antigens in preterm and term infant cord blood monocytes. Neonatology 2007; 94:8-15.
35. Neurath AR, Strick N, Li YY. Cells transfected with human interleukin 6 cDNA acquire binding sites for the hepatitis B virus envelope protein. J Exp Med 1992; 176:1561-1569.
36. Achary K, Mandal N, Mishra S, Sarangi S, Kar S, Satapathy A, et al. Maternal filarial infection: association of anti-sheath antibody responses with plasma levels of IFN-γ and IL-10. Parasitology 2013; 140:598-603.
37. Weissenbacher T, Laubender RP, Witkin SS, Gingelmaier A, Schiessl B, Kainer F, et al. Diagnostic biomarkers of pro-inflammatory immune-mediated preterm birth. Arch Gynecol Obstet 2013; 287:673-685.
38. Ferguson KK, McElrath TF, Chen YH, Mukherjee B, Meeker JD. Longitudinal profiling of inflammatory cytokines and C‐reactive protein during uncomplicated and preterm pregnancy. Am J Reprod Immunol 2014; 72:326-336.
39. Agrawal V, Smart K, Jilling T, Hirsch E. Surfactant protein (SP)-A suppresses preterm delivery and inflammation via TLR2. PloS One 2013; 8:e63990.
40. do Prado KM, Correa‐Silva S, Oliveira LG, Camara NOS, Ono É, Sandri S, et al. Indoleamine 2, 3‐dioxygenase (IDO) activity in placental compartments of renal‐transplanted pregnant women. Am J Reprod Immunol 2014; 72:45-56.
41. Schumacher A, Costa SD, Zenclussen AC. Endocrine factors modulating immune responses in pregnancy. Front Immunol 2014; 8:196.
42. Zhang A, Fu J, Ning B, Li D, Sun N, Wei W, et al. Tolerogenic dendritic cells generated with IL-10/TGFβ1 relieve immune thrombocytopenia in mice. Thromb Res 2013; 132 (1):63-68.
43. Alijotas-Reig J, Llurba E, Gris JM. Potentiating maternal immune tolerance in pregnancy: A new challenging role for regulatory T cells. Placenta 2014; 35:241-248.
44. Teng CB, Diao HL, Ma H, Cong J, Yu H, Ma XH, et al. Signal transducer and activator of transcription 3 (Stat3) expression and activation in rat uterus during early pregnancy. Reproduction 2004; 128:197-205.
45. Ladyman S, Grattan D. Region-specific reduction in leptin-induced phosphorylation of signal transducer and activator of transcription-3 (STAT3) in the rat hypothalamus is associated with leptin resistance during pregnancy. Endocrinology 2004; 145:3704-3711.
46. Hutchins AP, Diez D, Miranda-Saavedra D. The IL-10/STAT3-mediated anti-inflammatory response: recent developments and future challenges. Brief Funct Genomics 2013; 12:489-498.
47. Menon R, Fortunato SJ, Velez Edwards DR, Williams SM. Association of genetic variants, ethnicity and preterm birth with amniotic fluid cytokine concentrations. Ann Hum Genet 2010; 74:165-183.
48. Simhan HN, Ryckman KK, Williams SM, Krohn MA. Genetic regulation of cervical antiinflammatory cytokine concentrations during pregnancy. Am J Obstet Gynecol 2008; 199:163. e1-. e11.
49. Abu-Maziad A, Schaa K, Bell EF, Dagle JM, Cooper M, Marazita ML, et al. Role of polymorphic variants as genetic modulators of infection in neonatal sepsis. Pediatr Res 2010; 68:323-329.
50. Warren JE, Nelson LM, Stoddard GJ, Esplin MS,
Varner MW, Silver RM. Polymorphisms in the promoter region of the interleukin-10 (IL-10) gene in women with cervical insufficiency. Am J Obstet Gynecol 2009; 201:372. e1-. e5.
51. Speer EM, Gentile DA, Zeevi A, Pillage G, Huo D, Skoner DP. Role of single nucleotide polymorphisms of cytokine genes in spontaneous preterm delivery. Hum Immunol 2006; 67:915-923.
52. Kerk J, Dördelmann M, Bartels DB, Brinkhaus M-J, Dammann CE, Dörk T, et al. Multiplex measurement of cytokine/receptor gene polymorphisms and interaction between interleukin-10 (-1082) genotype and chorioamnionitis in extreme preterm delivery. J Soc Gynecol Invest 2006; 13:350-356.
53. Annells MF, Hart PH, Mullighan CG, Heatley SL, Robinson JS, Bardy P, et al. Interleukins-1, -4, -6, -10, tumor necrosis factor, transforming growth factor-beta, FAS, and mannose-binding protein C gene polymorphisms in Australian women: Risk of preterm birth. Am J Obstet Gynecol 2004; 191:2056-2067.
54. Sugita N, Kobayashi T, Kikuchi A, Shimada Y, Hirano E, Sasahara J, et al. Immunoregulatory gene polymorphisms in Japanese women with preterm births and periodontitis. J Reprod Immunol 2012; 93:94-101.
55. Moura E, Mattar R, de Souza E, Torloni MR, Gonçalves-Primo A, Daher S. Inflammatory cytokine gene polymorphisms and spontaneous preterm birth. J Reprod Immunol 2009; 80:115-121.
56. Stonek F, Metzenbauer M, Hafner E, Philipp K, Tempfer C. Interleukin‐10− 1082 G/A promoter polymorphism and pregnancy complications: results of a prospective cohort study in 1,616 pregnant women. Acta Obstet Gynecol Scand 2008; 87:430-433.
57. Mattar R, de Souza E, Daher S. Preterm delivery and cytokine gene polymorphisms. J Reprod Med 2006; 51:317-320.